nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—Kidney function abnormal—Ramipril—type 1 diabetes mellitus	0.0327	0.0375	CcSEcCtD
Cevimeline—Parosmia—Ramipril—type 1 diabetes mellitus	0.0244	0.0279	CcSEcCtD
Cevimeline—Neuralgia—Ramipril—type 1 diabetes mellitus	0.0228	0.0261	CcSEcCtD
Cevimeline—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.0191	0.0219	CcSEcCtD
Cevimeline—Glossitis—Ramipril—type 1 diabetes mellitus	0.0172	0.0197	CcSEcCtD
Cevimeline—Leukocytosis—Ramipril—type 1 diabetes mellitus	0.0168	0.0193	CcSEcCtD
Cevimeline—Hearing impaired—Ramipril—type 1 diabetes mellitus	0.0166	0.019	CcSEcCtD
Cevimeline—Vasculitis—Ramipril—type 1 diabetes mellitus	0.0162	0.0186	CcSEcCtD
Cevimeline—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.0154	0.0176	CcSEcCtD
Cevimeline—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.0149	0.0171	CcSEcCtD
Cevimeline—Neuropathy—Ramipril—type 1 diabetes mellitus	0.0149	0.017	CcSEcCtD
Cevimeline—Urine output increased—Ramipril—type 1 diabetes mellitus	0.0143	0.0164	CcSEcCtD
Cevimeline—Polyuria—Ramipril—type 1 diabetes mellitus	0.0131	0.015	CcSEcCtD
Cevimeline—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.013	0.0148	CcSEcCtD
Cevimeline—Deafness—Ramipril—type 1 diabetes mellitus	0.0128	0.0147	CcSEcCtD
Cevimeline—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.0128	0.0147	CcSEcCtD
Cevimeline—Amnesia—Ramipril—type 1 diabetes mellitus	0.0122	0.014	CcSEcCtD
Cevimeline—Renal impairment—Ramipril—type 1 diabetes mellitus	0.0121	0.0138	CcSEcCtD
Cevimeline—Purpura—Ramipril—type 1 diabetes mellitus	0.0119	0.0136	CcSEcCtD
Cevimeline—Arthritis—Ramipril—type 1 diabetes mellitus	0.0118	0.0135	CcSEcCtD
Cevimeline—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.0118	0.0135	CcSEcCtD
Cevimeline—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.0115	0.0132	CcSEcCtD
Cevimeline—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.0105	0.012	CcSEcCtD
Cevimeline—Gastritis—Ramipril—type 1 diabetes mellitus	0.0102	0.0116	CcSEcCtD
Cevimeline—Asthma—Ramipril—type 1 diabetes mellitus	0.00993	0.0114	CcSEcCtD
Cevimeline—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00993	0.0114	CcSEcCtD
Cevimeline—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00983	0.0113	CcSEcCtD
Cevimeline—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00977	0.0112	CcSEcCtD
Cevimeline—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00967	0.0111	CcSEcCtD
Cevimeline—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00967	0.0111	CcSEcCtD
Cevimeline—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00955	0.0109	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00923	0.0106	CcSEcCtD
Cevimeline—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00915	0.0105	CcSEcCtD
Cevimeline—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00906	0.0104	CcSEcCtD
Cevimeline—Weight increased—Ramipril—type 1 diabetes mellitus	0.00904	0.0103	CcSEcCtD
Cevimeline—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00873	0.00999	CcSEcCtD
Cevimeline—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00868	0.00994	CcSEcCtD
Cevimeline—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00868	0.00994	CcSEcCtD
Cevimeline—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00863	0.00988	CcSEcCtD
Cevimeline—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00861	0.00985	CcSEcCtD
Cevimeline—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00861	0.00985	CcSEcCtD
Cevimeline—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00835	0.00956	CcSEcCtD
Cevimeline—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00831	0.00951	CcSEcCtD
Cevimeline—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00826	0.00946	CcSEcCtD
Cevimeline—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00783	0.00896	CcSEcCtD
Cevimeline—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00766	0.00877	CcSEcCtD
Cevimeline—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00741	0.00848	CcSEcCtD
Cevimeline—Flushing—Ramipril—type 1 diabetes mellitus	0.00738	0.00845	CcSEcCtD
Cevimeline—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.0071	0.00813	CcSEcCtD
Cevimeline—Alopecia—Ramipril—type 1 diabetes mellitus	0.00702	0.00804	CcSEcCtD
Cevimeline—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00692	0.00792	CcSEcCtD
Cevimeline—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00678	0.00776	CcSEcCtD
Cevimeline—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00665	0.00762	CcSEcCtD
Cevimeline—Tremor—Ramipril—type 1 diabetes mellitus	0.00648	0.00742	CcSEcCtD
Cevimeline—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00642	0.00735	CcSEcCtD
Cevimeline—Agitation—Ramipril—type 1 diabetes mellitus	0.00636	0.00728	CcSEcCtD
Cevimeline—Malaise—Ramipril—type 1 diabetes mellitus	0.00624	0.00714	CcSEcCtD
Cevimeline—Vertigo—Ramipril—type 1 diabetes mellitus	0.00622	0.00712	CcSEcCtD
Cevimeline—Syncope—Ramipril—type 1 diabetes mellitus	0.0062	0.0071	CcSEcCtD
Cevimeline—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00619	0.00709	CcSEcCtD
Cevimeline—Palpitations—Ramipril—type 1 diabetes mellitus	0.00611	0.007	CcSEcCtD
Cevimeline—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00608	0.00696	CcSEcCtD
Cevimeline—Cough—Ramipril—type 1 diabetes mellitus	0.00604	0.00691	CcSEcCtD
Cevimeline—Convulsion—Ramipril—type 1 diabetes mellitus	0.00599	0.00686	CcSEcCtD
Cevimeline—Chest pain—Ramipril—type 1 diabetes mellitus	0.00589	0.00674	CcSEcCtD
Cevimeline—Myalgia—Ramipril—type 1 diabetes mellitus	0.00589	0.00674	CcSEcCtD
Cevimeline—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00589	0.00674	CcSEcCtD
Cevimeline—Anxiety—Ramipril—type 1 diabetes mellitus	0.00587	0.00672	CcSEcCtD
Cevimeline—Discomfort—Ramipril—type 1 diabetes mellitus	0.00582	0.00666	CcSEcCtD
Cevimeline—Confusional state—Ramipril—type 1 diabetes mellitus	0.00569	0.00652	CcSEcCtD
Cevimeline—Oedema—Ramipril—type 1 diabetes mellitus	0.00565	0.00647	CcSEcCtD
Cevimeline—Shock—Ramipril—type 1 diabetes mellitus	0.00556	0.00636	CcSEcCtD
Cevimeline—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00554	0.00634	CcSEcCtD
Cevimeline—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00553	0.00633	CcSEcCtD
Cevimeline—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00551	0.00631	CcSEcCtD
Cevimeline—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00548	0.00628	CcSEcCtD
Cevimeline—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00546	0.00625	CcSEcCtD
Cevimeline—Anorexia—Ramipril—type 1 diabetes mellitus	0.00538	0.00616	CcSEcCtD
Cevimeline—Hypotension—Ramipril—type 1 diabetes mellitus	0.00528	0.00604	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00514	0.00589	CcSEcCtD
Cevimeline—Insomnia—Ramipril—type 1 diabetes mellitus	0.00511	0.00585	CcSEcCtD
Cevimeline—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00507	0.00581	CcSEcCtD
Cevimeline—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00503	0.00576	CcSEcCtD
Cevimeline—Somnolence—Ramipril—type 1 diabetes mellitus	0.00502	0.00575	CcSEcCtD
Cevimeline—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00497	0.00569	CcSEcCtD
Cevimeline—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00491	0.00562	CcSEcCtD
Cevimeline—Fatigue—Ramipril—type 1 diabetes mellitus	0.00487	0.00557	CcSEcCtD
Cevimeline—Constipation—Ramipril—type 1 diabetes mellitus	0.00483	0.00553	CcSEcCtD
Cevimeline—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00465	0.00533	CcSEcCtD
Cevimeline—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00462	0.00529	CcSEcCtD
Cevimeline—Urticaria—Ramipril—type 1 diabetes mellitus	0.00449	0.00514	CcSEcCtD
Cevimeline—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00446	0.00511	CcSEcCtD
Cevimeline—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00446	0.00511	CcSEcCtD
Cevimeline—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00416	0.00476	CcSEcCtD
Cevimeline—Asthenia—Ramipril—type 1 diabetes mellitus	0.00405	0.00464	CcSEcCtD
Cevimeline—Pruritus—Ramipril—type 1 diabetes mellitus	0.004	0.00457	CcSEcCtD
Cevimeline—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00386	0.00442	CcSEcCtD
Cevimeline—Dizziness—Ramipril—type 1 diabetes mellitus	0.00373	0.00428	CcSEcCtD
Cevimeline—Vomiting—Ramipril—type 1 diabetes mellitus	0.00359	0.00411	CcSEcCtD
Cevimeline—Rash—Ramipril—type 1 diabetes mellitus	0.00356	0.00408	CcSEcCtD
Cevimeline—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00356	0.00407	CcSEcCtD
Cevimeline—Headache—Ramipril—type 1 diabetes mellitus	0.00354	0.00405	CcSEcCtD
Cevimeline—Nausea—Ramipril—type 1 diabetes mellitus	0.00335	0.00384	CcSEcCtD
Cevimeline—CHRM3—G alpha (q) signalling events—ITPR3—type 1 diabetes mellitus	0.00067	0.00529	CbGpPWpGaD
Cevimeline—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB1—type 1 diabetes mellitus	0.000659	0.0052	CbGpPWpGaD
Cevimeline—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB1—type 1 diabetes mellitus	0.000657	0.00519	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Other—CCR5—type 1 diabetes mellitus	0.00063	0.00498	CbGpPWpGaD
Cevimeline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.000616	0.00486	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR3—type 1 diabetes mellitus	0.000601	0.00475	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR3—type 1 diabetes mellitus	0.000599	0.00473	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000583	0.00461	CbGpPWpGaD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.000578	0.00457	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.000577	0.00455	CbGpPWpGaD
Cevimeline—CHRM1—Calcium Regulation in the Cardiac Cell—PRKCQ—type 1 diabetes mellitus	0.000568	0.00448	CbGpPWpGaD
Cevimeline—CHRM3—Calcium Regulation in the Cardiac Cell—PRKCQ—type 1 diabetes mellitus	0.000566	0.00447	CbGpPWpGaD
Cevimeline—CHRM3—Regulation of insulin secretion—INS—type 1 diabetes mellitus	0.00056	0.00442	CbGpPWpGaD
Cevimeline—CHRM1—Regulation of Actin Cytoskeleton—VAV1—type 1 diabetes mellitus	0.000551	0.00435	CbGpPWpGaD
Cevimeline—CHRM3—Regulation of Actin Cytoskeleton—VAV1—type 1 diabetes mellitus	0.000549	0.00434	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.000533	0.00421	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.000531	0.0042	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.000527	0.00416	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.000527	0.00416	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.000525	0.00415	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.000525	0.00415	CbGpPWpGaD
Cevimeline—CYP3A4—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.000498	0.00393	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.000496	0.00391	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.000494	0.0039	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000492	0.00389	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—GCG—type 1 diabetes mellitus	0.000492	0.00388	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—GCG—type 1 diabetes mellitus	0.00049	0.00387	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—PRKCQ—type 1 diabetes mellitus	0.000473	0.00374	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—PRKCQ—type 1 diabetes mellitus	0.000472	0.00373	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—HBA1—type 1 diabetes mellitus	0.000463	0.00366	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—APOC3—type 1 diabetes mellitus	0.00046	0.00364	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000452	0.00357	CbGpPWpGaD
Cevimeline—CHRM3—Integration of energy metabolism—INS—type 1 diabetes mellitus	0.00044	0.00348	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 1 diabetes mellitus	0.00044	0.00347	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 1 diabetes mellitus	0.000438	0.00346	CbGpPWpGaD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.000424	0.00335	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—type 1 diabetes mellitus	0.000423	0.00334	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.000423	0.00334	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—type 1 diabetes mellitus	0.000422	0.00333	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.000406	0.00321	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.000405	0.0032	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.000401	0.00317	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.000401	0.00317	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.0004	0.00316	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.0004	0.00316	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000393	0.00311	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.000377	0.00298	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.000376	0.00297	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.000365	0.00289	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.000364	0.00288	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.000364	0.00287	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.000363	0.00286	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—GCG—type 1 diabetes mellitus	0.00036	0.00285	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.000317	0.0025	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.000316	0.0025	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—CAT—type 1 diabetes mellitus	0.000305	0.00241	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.000304	0.0024	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.000303	0.00239	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—CDK4—type 1 diabetes mellitus	0.000293	0.00231	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—NOS2—type 1 diabetes mellitus	0.000284	0.00225	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—SST—type 1 diabetes mellitus	0.000278	0.0022	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—SST—type 1 diabetes mellitus	0.000277	0.00219	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.000277	0.00219	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.000276	0.00218	CbGpPWpGaD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.000275	0.00217	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.000274	0.00216	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000257	0.00203	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.000248	0.00196	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.000247	0.00195	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.000235	0.00186	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.000235	0.00185	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.000231	0.00183	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00023	0.00182	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.000229	0.00181	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.000229	0.00181	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.000227	0.00179	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.000226	0.00179	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—HBA2—type 1 diabetes mellitus	0.000225	0.00178	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	0.000221	0.00174	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—type 1 diabetes mellitus	0.00022	0.00174	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.000213	0.00168	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.000213	0.00168	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—G6PC2—type 1 diabetes mellitus	0.000212	0.00167	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000208	0.00165	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000208	0.00164	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000206	0.00163	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000206	0.00163	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000205	0.00162	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000205	0.00162	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—INS—type 1 diabetes mellitus	0.000202	0.0016	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000194	0.00153	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000193	0.00152	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000191	0.00151	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000191	0.00151	CbGpPWpGaD
Cevimeline—CHRM1—Regulation of Actin Cytoskeleton—EGFR—type 1 diabetes mellitus	0.000188	0.00149	CbGpPWpGaD
Cevimeline—CHRM3—Regulation of Actin Cytoskeleton—EGFR—type 1 diabetes mellitus	0.000188	0.00148	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—ALB—type 1 diabetes mellitus	0.000186	0.00147	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ABCC8—type 1 diabetes mellitus	0.000183	0.00145	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000179	0.00142	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000179	0.00141	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000179	0.00141	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000178	0.00141	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—NOS3—type 1 diabetes mellitus	0.000178	0.0014	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000174	0.00137	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000173	0.00137	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000163	0.00128	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000162	0.00128	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000157	0.00124	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000157	0.00124	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000157	0.00124	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000156	0.00123	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000145	0.00115	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000143	0.00113	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000142	0.00112	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000142	0.00112	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000142	0.00112	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.00014	0.00111	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.00014	0.00111	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.00014	0.00111	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.00014	0.0011	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000135	0.00107	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	0.000135	0.00106	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000134	0.00106	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000131	0.00103	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000131	0.00103	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000131	0.00103	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00013	0.00103	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000127	0.00101	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000127	0.001	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	0.000127	0.001	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000123	0.000972	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000123	0.000969	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000122	0.000968	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ITPR3—type 1 diabetes mellitus	0.000122	0.000967	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000122	0.000964	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000122	0.000961	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000122	0.000961	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000121	0.000958	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000121	0.000958	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000119	0.00094	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000119	0.000937	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000119	0.000937	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000118	0.000934	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—HBA1—type 1 diabetes mellitus	0.000115	0.00091	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—APOC3—type 1 diabetes mellitus	0.000115	0.000905	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000114	0.000904	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000114	0.000901	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—IL6—type 1 diabetes mellitus	0.000114	0.0009	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GSTT1—type 1 diabetes mellitus	0.000112	0.000888	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	0.00011	0.000867	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000108	0.000853	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000108	0.00085	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000103	0.000811	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000102	0.000809	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000101	0.0008	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000101	0.000798	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	9.98e-05	0.000789	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	9.95e-05	0.000786	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	9.67e-05	0.000764	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SH2B3—type 1 diabetes mellitus	9.63e-05	0.000761	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOC3—type 1 diabetes mellitus	9.61e-05	0.000759	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IAPP—type 1 diabetes mellitus	9.61e-05	0.000759	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOC3—type 1 diabetes mellitus	9.58e-05	0.000756	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IAPP—type 1 diabetes mellitus	9.58e-05	0.000756	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	9.2e-05	0.000727	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CCR5—type 1 diabetes mellitus	9.17e-05	0.000724	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	9.07e-05	0.000716	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	9.04e-05	0.000714	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GCG—type 1 diabetes mellitus	8.96e-05	0.000708	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	8.8e-05	0.000695	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	8.67e-05	0.000685	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SST—type 1 diabetes mellitus	8.43e-05	0.000666	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SST—type 1 diabetes mellitus	8.41e-05	0.000664	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	8.4e-05	0.000663	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ADRB1—type 1 diabetes mellitus	8.37e-05	0.000661	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	8.27e-05	0.000654	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CAT—type 1 diabetes mellitus	7.59e-05	0.000599	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GCG—type 1 diabetes mellitus	7.52e-05	0.000594	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GCG—type 1 diabetes mellitus	7.49e-05	0.000592	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	7.32e-05	0.000578	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	7.24e-05	0.000572	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	7.21e-05	0.00057	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	7.17e-05	0.000567	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—VAV1—type 1 diabetes mellitus	7.03e-05	0.000555	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	7.01e-05	0.000554	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—VAV1—type 1 diabetes mellitus	7e-05	0.000553	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CXCL10—type 1 diabetes mellitus	6.99e-05	0.000552	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	6.89e-05	0.000544	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	6.85e-05	0.000541	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	6.72e-05	0.000531	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	6.39e-05	0.000505	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—TYK2—type 1 diabetes mellitus	6.37e-05	0.000503	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	6.36e-05	0.000503	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IGF2—type 1 diabetes mellitus	6.34e-05	0.000501	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CD86—type 1 diabetes mellitus	6.13e-05	0.000484	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CD86—type 1 diabetes mellitus	6.11e-05	0.000483	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	5.85e-05	0.000462	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—IL2—type 1 diabetes mellitus	5.83e-05	0.000461	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.81e-05	0.000459	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.8e-05	0.000458	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	5.67e-05	0.000448	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.53e-05	0.000437	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.51e-05	0.000435	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.43e-05	0.000429	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.42e-05	0.000428	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	5.36e-05	0.000423	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.36e-05	0.000423	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.34e-05	0.000422	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.32e-05	0.00042	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.3e-05	0.000419	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—INS—type 1 diabetes mellitus	5.04e-05	0.000398	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	4.79e-05	0.000378	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ALB—type 1 diabetes mellitus	4.62e-05	0.000365	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	4.54e-05	0.000358	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	4.5e-05	0.000356	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	4.48e-05	0.000354	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	4.47e-05	0.000353	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CD80—type 1 diabetes mellitus	4.46e-05	0.000352	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NOS3—type 1 diabetes mellitus	4.42e-05	0.000349	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	4.4e-05	0.000347	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—INS—type 1 diabetes mellitus	4.22e-05	0.000334	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—INS—type 1 diabetes mellitus	4.21e-05	0.000333	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.09e-05	0.000323	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.07e-05	0.000322	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.07e-05	0.000321	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.05e-05	0.00032	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.77e-05	0.000298	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.76e-05	0.000297	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.7e-05	0.000293	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.69e-05	0.000292	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	3.5e-05	0.000277	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.14e-05	0.000248	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	3.14e-05	0.000248	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.13e-05	0.000248	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL2—type 1 diabetes mellitus	3.13e-05	0.000247	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.12e-05	0.000247	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.11e-05	0.000246	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	3.01e-05	0.000238	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	2.97e-05	0.000234	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	2.76e-05	0.000218	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.64e-05	0.000209	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	2.64e-05	0.000209	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.63e-05	0.000208	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.4e-05	0.00019	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.39e-05	0.000189	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	1.97e-05	0.000155	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.85e-05	0.000146	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL6—type 1 diabetes mellitus	1.84e-05	0.000145	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	1.8e-05	0.000143	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	1.73e-05	0.000136	CbGpPWpGaD
